Literature DB >> 2399980

Gastrointestinal motor effects of erythromycin.

M F Otterson1, S K Sarna.   

Abstract

We studied the small intestinal motor effects of oral and intravenous (iv) erythromycin in 10 conscious dogs. After control recordings with placebo, oral or iv erythromycin was given at 40% of the migrating motor complex (MMC) cycle. Recordings were made after administration until normal contractile activity had returned or 12 h postdrug administration. Low doses initiated a premature MMC. High doses, however, prolonged the MMC cycle length. Erythromycin reduced the MMC propagation velocity at all doses. Both oral and iv erythromycin induced amyogenesia. During this pattern, electrical control activity was obliterated in the proximal and destabilized in the distal small intestine. Erythromycin also increased the incidence of retrograde giant contractions (RGCs) and vomiting. These effects occurred within the first 2 h after oral and within the first 30 min after iv administration. The incidence of giant migrating contractions (GMCs) increased significantly from 5 to 12 h but not from 0 to 5 h after administration. The distance of origination of GMCs from the ileocolonic junction was significantly increased from 5 to 12 h. The amplitude ratio, duration, and velocity of migration of GMCs induced after erythromycin were similar to control values. Clusters of coordinated antral and duodenal contractions also occurred early after administration. Our findings suggest that erythromycin has multiple motor effects on the stomach and small intestine. Diarrhea, abdominal cramping, and vomiting associated with erythromycin may be related to increased incidence of GMCs and RGCs. Erythromycin has a biphasic effect on MMC cycle length, initiating premature MMCs at low doses and prolonging their cycle length at higher doses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2399980     DOI: 10.1152/ajpgi.1990.259.3.G355

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  33 in total

1.  Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.

Authors:  P C Ng; K W So; K S Fung; C H Lee; T F Fok; E Wong; W Wong; K L Cheung; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 2.  Gastrointestinal motility in acute illness.

Authors:  Sonja Fruhwald; Peter Holzer; Helfried Metzler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 3.  Effects of radiation upon gastrointestinal motility.

Authors:  Mary F Otterson
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

4.  Effects of electroacupuncture on gastric migrating myoelectrical complex in dogs.

Authors:  L Qian; L J Peters; J D Chen
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

5.  Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beings.

Authors:  F Caron; M Bouaniche; F Delatour; P Ducrotte; J C Torlotin; P Denis; G Humbert; B Rouveix
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Cephalosporin antibiotics accelerate gastric emptying in mice.

Authors:  W H Kuo; K S Wadwa; C D Ferris
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

7.  Effect of erythromycin on interdigestive gastrointestinal contractile activity and plasma motilin concentration in humans.

Authors:  O Kawamura; T Sekiguchi; M Kusano; T Nishioka; Z Itoh
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

8.  Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways.

Authors:  S Fiorucci; R Bosso; A Morelli
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

9.  Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy.

Authors:  S M Catnach; A B Ballinger; M Stevens; P D Fairclough; R C Trembath; P L Drury; P J Watkins
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

10.  Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis.

Authors:  X Y Qin; M A Pilot; H Thompson; M Scott
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.